Jana Macon
About Jana Macon
Jana Macon serves as the President of Curve Dental, a position she has held since 2023. With over 25 years of experience in the SaaS and medical markets, she has held various leadership roles, including Chief Operating Officer and EVP Customer Success at Curve Dental and multiple vice president positions at Brightree.
Current Role at Curve Dental
Jana Macon currently serves as the President of Curve Dental, a position she has held since 2023. In this role, she oversees the strategic direction and operational management of the company. Her leadership is focused on enhancing customer success and driving growth within the dental software industry.
Previous Experience at Curve Dental
Before becoming President, Jana Macon worked at Curve Dental as Chief Operating Officer from 2021 to 2023 and as EVP Customer Success from 2019 to 2021. During her tenure, she contributed to the company's operational efficiency and customer satisfaction initiatives, leveraging her extensive experience in the SaaS sector.
Professional Background in Healthcare Technology
Jana Macon has a significant background in healthcare technology, having worked at Brightree in various leadership roles from 2006 to 2017. Her positions included VP Home Health and Hospice, VP Strategic Services, and VP Professional Services. She played a crucial role in Brightree's growth, helping the company expand its workforce and achieve substantial revenue milestones.
Education and Qualifications
Jana Macon earned a Bachelor of Science degree in Computer Science from Christopher Newport University, where she studied from 1991 to 1994. Her educational background has equipped her with the technical knowledge necessary for her roles in the SaaS and medical markets.
Key Achievements at Brightree
During her time at Brightree, Jana Macon was instrumental in the company's expansion, contributing to a workforce of over 500 employees and achieving $130 million in revenue. She was also a key member of the leadership team that secured over 50% market share and participated in the sale of Brightree to ResMed for $800 million in April 2016.